Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2480-2485

  Kärpänoja, Pauliina ^a,p   Nyberg, Solja T ^b   Bergman, Miika ^b   Voipio, Tinna ^c   Paakkari, Pirkko ^c   Huovinen, Pentti ^b,ab   Sarkkinen, Hannu ^a,p   Carlson, Petteri ^d   Rautio, Merja ^d   Renkonen, Risto ^e   Muotiala, Anna ^e   Vaara, Martti ^f   Tarkka, Eveliina ^f   Karttunen, Riitta ^g   Ojanen, Tarja ^g   Karhukorpi, Jari ^h   Nissinen, Antti ⁱ   Ruuska, Pekka ^j   Jägerroos, Henrik ^k   Larikka, Martti ^l   Räisänen, Simo ^m   Larinkari, Ulla ⁿ   Forsblom, Benita ⁿ   Kärkkäinen, Ulla ^o   Kauppinen, Maritta ^q   Paltemaa, Seppo ^q   Kärkkäinen, Päivi ^r,s   Koskela, Markku ^t   Pajarre, Sini ^u   Manninen, Raija ^u   Oinonen, Sinikka ^v   Ratia, Virpi ^v   Grönroos, Paul ^w   Vuento, Risto ^x   Liimatainen, Oili ^x   Siro, Maj Rita ^y   Eerola, Erkki ^z   Meurman, Olli ^aa   Rantakokko Jalava, Kaisu ^aa   Kaukoranta, Suvi Sirkku ^ab   Lager, Katrina ^ac   more..

^a Clinical Microbiology   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NATIONAL AGENCY FOR MEDICINES   (Finland)

^d JORVI HOSPITAL   (Finland)

^e Medix Diacor Laboratories

^f Medix Diacor Laboratories ^*

^g KANTA HÄME CENTRAL HOSPITAL   (Finland)

^h Pohjois Karjala Central Hospital

ⁱ Keski Suomi Central Hospital

^j KAINUU CENTRAL HOSPITAL   (Finland)

^k Lappi Central Hospital

^l Lansi Pohja Central Hospital   (Finland)

^m Keski Pohjanmaan Erikoissairaanhoito Ja Peruspalvelukuntayhtyma   (Finland)

ⁿ KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^o KUOPIO UNIVERSITY HOSPITAL   (Finland)

^p PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^q Etelä Karjala Central Hospital

^r MIKKELI CENTRAL HOSPITAL   (Finland)

^s Savonlinna Central Hospital   (Finland)

^t OULU UNIVERSITY HOSPITAL   (Finland)

^u SATAKUNTA CENTRAL HOSPITAL   (Finland)

^v SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^w Health Center Koskiklinikka

^x TAMPERE UNIVERSITY HOSPITAL   (Finland)

^y Health Center Pulssi   (Finland)

^z Turku University

^aa TURKU UNIVERSITY HOSPITAL   (Finland)

^ab VAASA CENTRAL HOSPITAL   (Finland)

^ac National Public Health Institute   (Romania)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; FINLAND; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

DRUG RESISTANCE, BACTERIAL; FINLAND; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 46249094460     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01118-07     Document Type: Article

References (23)

1. Arason, V. A., A. Gunnlaugsson, J. A. Sigurdson, H. Erlendsdottir, S. Gudmundsson, and K. G. Kristinsson. 2002. Clonal spread of resistant pneumococci despite diminished antimicrobial use. Microb. Drug Resist. 8:187-192.
2. Baquero, F., G. Baquero-Artiago, R. Canton, and C. Garcia-Rey. 2002. Antibiotic consumption and resistance selection in Streptococcus pneumoniae. J. Antimicrob. Chemother. 50(Suppl. S2):27-37.
3. Bean, D. C., D. M. Livermore, I. Papa, and L. M. C. Hall. 2005. Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J. Antimicrob. Chemother. 56:962-964.
4. Bergman, M., S. Huikko, M. Pihlajamäki, P. Laippala, E. Palva, P. Huovinen, H. Seppälä, and the Finnish Study Group for Antimicrobial Resistance (FiRe Network). 2004. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin. Infect. Dis. 38:1251-1256.
5. Calatayud, L., C. Ardanuy, E. Cercenado, A. Fenoll, E. Bouza, R. Pallares, R. Martin, and J. Linares. 2007. Serotypes, clones and mechanisms of resistance of erythromycin-rcsistant Streptococcus pneumoniae isolates collected in Spain. Antimicrob. Agents Chemother. 51:3240-3246.
6. Cizman, M., M. Pokorn, K. Seme, A. Orazem, and M. Paragi. 2001. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother. 47:475-477.
7. Cizman, M. 2003. The use and resistance to antibiotics in the community. Int. J. Antimicrob. Agents 21:297-307.
8. Clinical Laboratory Standards Institute. 2006. Methods for dilution antimicrobial tests for bacteria that grow aerobically; approved standard - 7th ed. Clinical Laboratory Standards Institute document M7-A7. CLSI, Wayne, PA.
9. Doern, G. V., S. S. Richter, A. Miller, N. Miller, C. Rice, K. Heilman, and S. Beekman. 2005. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin. Infect. Dis. 41:139-148.
10. Fuste, M. C., M. A. Pineda, J. Palomar, M. Vinas, and J. G. Loren. 1996. Clonality of multidrug-resistant nontypeable strains of Haemophilus influenzae. J. Clin. Microbiol. 34:2760-2765.
11. Garcia-Rey, C., L. Aguilar, F. Baquero, J. Casal, and J. E. Martin. 2002. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J. Clin. Microbiol. 40:2959-2963.
12. Hoban, D. J., G. V. Doern, A. C. Fluit, M. Roussel-Delvallez, and R. N. Jones. 2001. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S81-S93.
13. Huovinen, P. 2001. Resistance to SXT. Clin. Infect. Dis. 32:1608-1614.
14. Huovinen, P., L. Sundström, G. Swedberg, and O. Sköld. 1995. Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother. 39: 279-289.
15. Huovinen, P., L. Pulkkinen, H.-L. Helin, M. Mäkilä, and P. Toivanen. 1986. Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984. Antimicrob. Agents Chemother. 29:73-76.
16. Jordano, Q., V. Kalco, B. Almirante, A. M. Planes, O. del Valle, E. Ribera, O. Len, C. Pigrau, and A. Pahissa. 2004. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 38:1623-1628.
17. Kahlmeter, G., P. Menday, and O. Cars. 2003. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J. Antimicrob. Chemother. 52:1005-1010.
18. Mölstad, S., E. Arvidsson, I. Eliasson, B. Hovelius, C. Kamme, and C. Schalen. 1992. Production of betalactamase by respiratory tract bacteria in children: relationship to antibiotic use. Scand. J. Prim. Health Care 10:16-20.
19. Nissinen, A., P. Grönroos, P. Huovinen, E. Herva, M.-L. Katila, T. Klaukka, S. Kontiainen, O. Liimatainen, S. Oinonen, and P. H. Mäkelä. 1995. Development of (-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin. Infect. Dis. 21:1193-1196.
20. Pihlajamäki, M., P. Kotilainen, T. Kaurila, T. Klaukka, E. Palva, P. Huovinen, and the Finnish Study Group for Antimicrobial Resistance (FiRe Network). 2001. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin. Infect. Dis. 33:483-488.
21. Rautakorpi, U.-M., T. Klaukka, P. Honkanen, M. Mäkelä, T. Nikkarinen, E. Palva, R. Roine, H. Sarkkinen, and P. Huovinen on behalf of the MIKSTRA Collaborative Study Group. 2001. Antibiotic use by indication: a basis for active antibiotic policy in the community. Scand. J. Infect. Dis. 33:920-926.
22. Sahm, D. F., M. E. Jones, M. L. Hickey, D. R. Diakun, S. V. Mani, and C. Thornsberry. 2000. Resistance surveillance of Streptococcus pneumoniae. Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J. Antimicrob. Chemother. 45:457-466.
23. Seppälä, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, P. Huovinen, and the Finnish Study Group for Antimicrobial Resistance. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-446.